Navigation Links
Arteriocyte Takes the Lead in Promoting Building Future Pipeline of Women in STEM Career Fields
Date:12/13/2011

CLEVELAND, Dec. 13, 2011 /PRNewswire/ -- Don Brown, CEO of Arteriocyte Cellular Therapies Medical Systems (Arteriocyte) and Terri Sandu, Executive Director of Hard Hatted Women (HHW), are combining efforts to raise awareness of opportunities for women in Science, Technology, Engineering and Math (STEM) disciplines. They will inspire, celebrate and encourage women to choose careers and obtain the requisite education and training to thrive in STEM fields at a breakfast to be held tomorrow.

As a growing biotechnology company with a continual need for new, well-trained staff, Arteriocyte has always taken an active role in advancing the inclusion of women and minorities in STEM careers and education. While the percentage of women participating in these careers continues to increase, women still represent only 11% of working engineers and 32% of chemists.    

     WHEN: Wednesday, December 14, 2011, 8:00 am to 9:00 am
     WHERE: Arteriocyte Research and Development Center, The Baker Electric Building:
     7100 Euclid Avenue, Cleveland

About Arteriocyte:

Arteriocyte, a leading clinical stage biotechnology company, is dedicated in developing novel stem cell products and medical devices for unmet clinical needs. Arteriocyte leverages its expertise in stem cell and tissue engineering in order to develop a broad portfolio of cell based therapeutics to improve patient outcomes. In October of 2007, Arteriocyte partnered with DW Healthcare Partners and Comerica to create Arteriocyte Medical Systems Inc., in order to commercialize and distribute novel medical devices and point of care surgical solutions to address serious unmet medical needs in cardiac, orthopedic and vascular surgeries. Arteriocyte Medical Systems manufactures and distributes the Magellan™ Autologous Platelet Separator System.

About Hard Hatted Women:

Hard Hatted Women is a community based organization serving the state of Ohio dedicated to helping women get into and succeed in a broad range of non-traditional careers (where women are less than 25% of the workforce). Maintaining a continual strong presence in the Northeast Ohio region and the state since 1979, HHW boasts a long record of effectively assisting individuals, companies, and communities in reaching their goals for diversity and inclusiveness.


'/>"/>
SOURCE Arteriocyte
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Arteriocyte Receives $1 Million Award From Ohio Third Frontier Program to Advance Its NANEX™ Technology Toward Clinical Use
2. Arteriocyte and the U.S. Army Institute of Surgical Research (USAISR) Sign a CRADA to Speed Development of Cellular Therapies for Orthopaedic Trauma
3. Arteriocyte Receives FDA Approval to Move Forward with Critical Limb Ischemia Trial
4. Arteriocyte Named Top Biotech Start Up Venture by the Ohio Venture Association for 2010
5. Terminator-style info-vision takes step towards reality
6. New Kit Takes the Uncertainty Out of Lymphoma Diagnosis
7. Graphenes quantum leap takes electronics a step closer
8. Cord Blood America Announces Reverse Stock Split Takes Effect Monday, May 9, 2011
9. CPTA Takes a Step Toward Improving Patient Access to Physical Therapy Services
10. Computer memory takes a spin
11. Terso Solutions RFID Jump Start Takes the Risk Out of Implementing RFID for Hospitals and Research Laboratories Looking to Streamline Operations and Improve Regulatory Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology ... drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription ... is able to cross the cell membrane and bind intracellular STAT3 and inhibit ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it ... Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and CEO of ... Rotary Club. The event entitled “Stem Cells and Their Regenerative Powers,” ... Dr. Harman, DVM, MPVM was joined by two human doctors: Peter B. Hanson, ...
(Date:10/10/2017)... Oct. 10, 2017 SomaGenics announced the receipt ... to develop RealSeq®-SC (Single Cell), expected to be the ... RNAs (including microRNAs) from single cells using NGS methods. ... need to accelerate development of approaches to analyze the ... "New techniques for measuring levels of mRNAs in ...
Breaking Biology Technology:
(Date:4/11/2017)... , April 11, 2017 Crossmatch®, a ... authentication solutions, today announced that it has been ... Research Projects Activity (IARPA) to develop next-generation Presentation ... "Innovation has been a driving force ... program will allow us to innovate and develop ...
(Date:4/6/2017)... , April 6, 2017 ... RFID, ANPR, Document Readers, by End-Use (Transportation & Logistics, ... Facility, Oil, Gas & Fossil Generation Facility, Nuclear Power), ... Educational, Other) Are you looking for a ... sector? ...
(Date:4/4/2017)... --  EyeLock LLC , a leader of iris-based identity ... and Trademark Office (USPTO) has issued U.S. Patent No. ... iris image with a face image acquired in sequence ... th issued patent. "The issuance ... multi-modal biometric capabilities that have recently come to market ...
Breaking Biology News(10 mins):